The European Institute for Innovation Through Health Data’s Post

Health technologies can revolutionize #PublicHealth by enabling equitable, last-mile care. It is essential to support their scale-up and integration into health systems. In this article, Dr. Priyanka Bajaj and Dr. Swati Mahajan discuss PATH’s Impact Lab platform, which bridges the lab-to-market gap and accelerates the adoption of health technologies within health systems. Read here: https://bit.ly/47LbrTy Neeraj Jain Bhoomika Srivastava Blackfrog Technologies Ai Health Highway Briota Technologies Qure.ai Asian Development Bank (ADB)

HEALTH POLICY: The 18th edition of FICCI’s annual healthcare conference, #FICCIHEAL2024, themed ‘Swasth Bharat, Viksit Bharat,’ began with an impactful day of discussions that underscored India’s strategic drive toward healthcare transformation. Click to read: https://lnkd.in/gmFnAACu #healthpolicy #policy #healthtech #healthcare #medtech #innovation #AI #biovoicenews

Today I participated in a wonderful event organized by Digital Health Copenhagen - Meetup.com in collaboration withHealth Tech Hub Copenhagen Esteemed panelists, industry trends and predictions, startup pitches, networking with experts, founders and VC representatives. My insights on opportunities and challenges for AI in Healthcare in the near future: + AI and digital biomarkers - huge volumes of data and robust algorithms are allowing for discovery of new biomarkers, enabling deeper insights into various diseases. But also advance of the technology enables non-invasive diagnostics. + Healthcare digitalization - unanimously common view of the audience has been that reducing healthcare administration is a perfect low risk-high return use case for GenAI, addressing specific operational inefficiencies. One of the startups Saichologist was actually pitching the application of LLM augmented ERP for psychology practitioners. + Private actors are much easier to innovate with, as they are more sharply focused on ner-term cost saving. But even regions are catching up, with healthcare being the largest segment of public spending by a large margin. - Trustworthy AI and validation will stay a major hurdle. Application for "high risk-high return" areas is thus going to be muted until mechanistic interpretability (or other methods?) have matured. ? The USA is expected to double down on innovation with Elon Musk and JFK Jr at the helm, setting the trend for coming years. ? EU MDR and EU AI ACT are adding layers of complexity, especially for startups in the field. Risk aversion of EU may lead to further stagnation. Thanks Katalin Vikuk Mads-Jakob Vad Kristensen Manuel Montoya Catalá Constant Beroulle Isaac Tarek and others for the insightful conversations! And special kudos to Satyam Goel and Paula Petcu for organizing! #digitalhealthtech #copenhagen

Digital Twin technologies are set to revolutionise healthcare by creating virtual replicas of patients and healthcare systems, enabling personalised, data-driven care. Our expert panel, comprised of clinical practitioners, academics and industry leaders will explore how these innovations can enhance chronic diseases management, reproductive health & optimise operational efficiency within healthcare systems. Join us as we explore the various approaches driving this transformation, which will include the integration of AI and ML techniques and the role of computational biology. The discussion will also focus on the roadmap to clinical adoption, addressing key challenges such as validation, regulatory approval, cost-effectiveness, and success metrics. Don’t miss out on this exclusive opportunity to connect with healthcare practitioners and global leaders. Add-on the Beyond Health & Biomed Track when you register at https://lnkd.in/g-vhJjHJ Use SWITCH20 when registering for 20% off your Beyond add-on Panelists • Dean Ho • Dr Melvin Heng • Rinkoo Dalan • Pauline Erica Tay • Andrew Wu #SWITCHSG

In health innovation, evidence is key but commercials are often the kingmaker. A pleasure to present on research commercialisation at a Panacea Innovation and British Heart Foundation programme in Worcester College, Oxford last week. Thanks to Ross Thomson and Mina Elisha Bekheet for the invitation. Reflections from the day: 🎓 Even 5 years ago, talking commercialisation with clinicians and academics would be a "Why" conversation. Now it jumps straight to the "How" and "What" - even at the ideation stage. IMO this is a promising sign for clinically led innovation. 💰 Grant funders are getting much, much better at appraising commercial credibility. Investors are also getting much, much better at knowing what "good" evidence actually looks like. Bridging that gap is where innovative clinicians can play a huge role in Health Tech - especially as the baseline starts to rise. 📈 There's more and more case studies of promising technologies that stumble at the commercial hurdle. Potentially we're starting to see industry playbooks e.g. digital therapeutics having a clearer path to success than even 2 years ago. That's particularly exciting for Digital Health technologies. 🌐 I still find it interesting that whilst there's an increasing recognition of needing to understand each target market's nuance, we still tend to bunch markets together into supranational blocks. ☀️ The "Other Place" doesn't look half bad in summer..

Set your alarms: SFH2024 kicks off in just a few days! ⏰⏰⏰ We’ve been giving a lot of attention to our expert speaker talks, but it’s also important to share different perspectives and challenge each other. 🤔💡😀 To scratch that itch, the afternoon plenary will feature two panel discussions which we think will spark lively debates!   𝗧𝗵𝗲 𝘂𝘀𝗲 𝗼𝗳 𝗵𝗲𝗮𝗹𝘁𝗵 𝗱𝗮𝘁𝗮 𝗳𝗼𝗿 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗽𝘂𝗿𝗽𝗼𝘀𝗲𝘀 𝗶𝗻 𝗕𝗲𝗹𝗴𝗶𝘂𝗺: 𝗙𝗿𝗮𝗺𝗲𝘄𝗼𝗿𝗸, 𝗰𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲𝘀 𝗮𝗻𝗱 𝗼𝗽𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗶𝗺𝗽𝗹𝗲𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 This fireside chat brings together a panel of industry, academia and policy experts to share their experiences around the use of health data. 🔸Nicolas Dubois (Belgian Health Data Agency) 🔸David Smeets (Johnson & Johnson), 🔸Ingrid Maes (Inovigate), 🔸Philippe Kolh (University of Liège) 🔸Kim Luyckx Moderator: Liesbet M. PEETERS (Hasselt University) 𝗨𝗻𝗹𝗼𝗰𝗸𝗶𝗻𝗴 𝗔𝗜’𝘀 𝗽𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹 𝗶𝗻 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗮𝗻𝗱 𝗱𝗿𝘂𝗴 𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆: 𝗶𝘀 𝗕𝗲𝗹𝗴𝗶𝘂𝗺 𝗳𝗮𝗹𝗹𝗶𝗻𝗴 𝗯𝗲𝗵𝗶𝗻𝗱? Closing the program, this roundtable focuses on strategies, opportunities and solutions for Belgium to make the best use of AI in healthcare. 🔹Sari Depreeuw (Crowell & Moring) 🔹Jack Scannell (Etheros Pharmaceuticals) 🔹Ann Van Gysel (MEDVIA) 🔹Valerie Vandeweerd (Monsana) 🔹Ward Servaes (moveUP - digital therapies) Moderator: Bart Vannieuwenhuyse (formerly with J&J) There are only a few tickets left, so click the link below to get yours. We’ll see you in Brussels! 👋 Science for Health 📆12 November 2024 📍SQUARE, Brussels ✍️Registration: https://lnkd.in/gQpHPQ9 #sfh2024 #AI #bigdata #digitalhealth #healthinnovation #healthtech #medtech #biotech BioWin HST Group - Health, Science and Technology Group Pfizer UCB GSK KU Leuven Ghent University flanders.bio imec University of Antwerp VIB Université catholique de Louvain Université libre de Bruxelles Hasselt University University of Liège Université de Namur UMONS

Advances in healthcare are one of the greatest advantages of the times we live in and it's only getting more exciting (and profitable). Despite the geopolitical ructions going on around the world, there has hardly been a better time in human history to be alive - particularly as it concerns our physical health. The COVID-19 pandemic was a case in point of the extraordinary advances in medical technology. In hindsight, it’s quite mind-blowing how companies like Pfizer were so quickly able to harness existing and frontier therapies to map COVID-19 and produce a vaccine. And AI is set to be another game-changer. We’ve never had better opportunities to manage and treat our health concerns, and what makes it all more exciting is that the future of personalised treatments is already upon us.

About #HealthRevolutionCongress: 🏥 40% of the emergencies can be solved at the primary care center. This project by Mediktor and Hospital Universitari Arnau de Vilanova de Lleida utilizes technology to support patients and healthcare professionals in improving outcomes and reducing unnecessary waiting time (Oriol Yuguero Torres Oscar Garcia-Esquirol ) 🖥 Digital health is a driver for #valuebasedhealthcare. Technology empowers the patients, improves equity, and optimizes the healthcare system's performance. Marisa Merino: "All in digital health is about the people". (Mar Gomis Pastor Izabel Alfany Oscar Solans Fernandez) ⚙ The regulatory strategy should be included as part of the product inception, so time to market, costs, and challenges are minimized (Eurecat - Technology Centre ) 😊 Technology allows you to focus on what's important: the patients (Julian Isla ) 💊 AI supports the pharma industry and improves the quality of care shortening the research times and the time to deliver the products, but also building solutions for #prevention and driving #innovation at hospitals and healtcare systems (Jorge Pou Miguel Lancha Luquero Sergio Cortes Abad Paolo Cionini) Barcelona Health Hub Ruben Casado Arroyo

At the HLTH Conference 2024 in Amsterdam, Google’s Chief Health Officer, Dr. Karen DeSalvo, highlighted AI's transformative potential in healthcare, likening its impact to the discovery of penicillin. Dr. DeSalvo discussed how AI can address significant challenges such as burnout, cognitive burden, chronic diseases, and healthcare costs, emphasising its role in enhancing care, filling capability gaps, and scaling positive health outcomes globally. Google's initiatives, like the Med-Gemini LLM and AlphaFold, were cited as examples of AI advancing diagnostics and drug discovery. For MediRecords, these insights highlight the importance of integrating AI to improve patient care. By adopting AI technologies either directly or with partners, MediRecords can enhance the platform with advanced diagnostic tools, predictive analytics, and personalised treatment plans. AI integrations can help reduce clinician burnout, streamline workflows, and enhance health outcomes, aligning with the broader goal of democratising healthcare and improving health equity. As a leading cloud-based electronic health record provider, MediRecords is ready to bring AI and other enterprise solutions to Australian and overseas markets.

The creation of this shared data space for research represents a significant advancement in the use of digital twins and artificial intelligence applications in the healthcare sector. However, it is crucial that this progress goes hand in hand with the security and privacy protection of individuals' health data. We are committed to working tirelessly to ensure that this project serves as an example of excellence in data security and as a catalyst for the continuous improvement of social and healthcare services. #DigitalTwins #AIinHealthcare #DataSecurity #HealthDataPrivacy #HealthcareInnovation #ResearchAdvancements #SocialCare #ContinuousImprovement